Individualized therapy of HHT driven by network analysis of metabolomic profiles

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Jamshidi, Neema ^a   Miller, Franklin J ^b   Mandel, Jess ^c   Evans, Timothy ^d   Kuo, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BIOLOGICAL MODEL; CASE CONTROL STUDY; CASE REPORT; CLUSTER ANALYSIS; FEMALE; HUMAN; METABOLISM; METABOLOME; METHODOLOGY; PATHOLOGY; PERSONALIZED MEDICINE; PHYSIOLOGY; RENDU OSLER WEBER DISEASE; SYSTEMS BIOLOGY;

ANTIBODIES, MONOCLONAL, HUMANIZED; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; MODELS, BIOLOGICAL; SYSTEMS BIOLOGY; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 83655183165     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-200     Document Type: Article

References (32)

1. Sharathkumar AA, Shapiro A. Hereditary haemorrhagic telangiectasia. Haemophilia 2008, 14(6):1269-1280.
2. Almaas E, Kovacs B, Vicsek T, Oltvai ZN, Barabasi AL. Global organization of metabolic fluxes in the bacterium Escherichia coli. Nature 2004, 427(6977):839-843.
3. Balazsi G, Barabasi AL, Oltvai ZN. Topological units of environmental signal processing in the transcriptional regulatory network of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(22):7841-7846.
4. Beg QK, Vazquez A, Ernst J, de Menezes MA, Bar-Joseph Z, Barabasi AL, Oltvai ZN. Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(31):12663-12668.
5. Bordbar A, Lewis NE, Schellenberger J, Palsson BO, Jamshidi N. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Molecular systems biology 2010, 6:422.
6. Cakir T, Efe C, Dikicioglu D, Hortacsu A, Kirdar B, Oliver SG. Flux balance analysis of a genome-scale yeast model constrained by exometabolomic data allows metabolic system identification of genetically different strains. Biotechnol Prog 2007, 23(2):320-326.
7. Gianchandani EP, Oberhardt MA, Burgard AP, Maranas CD, Papin JA. Predicting biological system objectives de novo from internal state measurements. BMC Bioinformatics 2008, 9:43.
8. Jerby L, Shlomi T, Ruppin E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Molecular systems biology 2010, 6:401.
9. Llaneras F, Pico J. Stoichiometric modelling of cell metabolism. J Biosci Bioeng 2008, 105(1):1-11.
10. Manichaikul A, Ghamsari L, Hom EF, Lin C, Murray RR, Chang RL, Balaji S, Hao T, Shen Y, Chavali AK, et al. Metabolic network analysis integrated with transcript verification for sequenced genomes. Nat Methods 2009, 6(8):589-592.
11. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA. Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 2010, 192(20):5534-5548.
12. Oberhardt MA, Palsson BO, Papin JA. Applications of genome-scale metabolic reconstructions. Molecular systems biology 2009, 5:320.
13. Patil KR, Nielsen J. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(8):2685-2689.
14. Raghunathan A, Reed J, Shin S, Palsson B, Daefler S. Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction. BMC Syst Biol 2009, 3:38.
15. Roberts SB, Robichaux JL, Chavali AK, Manque PA, Lee V, Lara AM, Papin JA, Buck GA. Proteomic and network analysis characterize stage-specific metabolism in Trypanosoma cruzi. BMC Syst Biol 2009, 3:52.
16. Rocha I, Forster J, Nielsen J. Design and application of genome-scale reconstructed metabolic models. Methods Mol Biol 2008, 416:409-431.
17. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(6):1777-1782.
18. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). American journal of medical genetics 2000, 91(1):66-67.
19. Mo ML, Jamshidi N, Palsson BO. A genome-scale, constraint-based approach to systems biology of human metabolism. Molecular bioSystems 2007, 3(9):598-603.
20. Orth JD, Thiele I, Palsson BO. What is flux balance analysis?. Nature biotechnology 2010, 28(3):245-248.
21. Palsson BO. Systems Biology: Determining the Capabilities of Reconstructed Networks. 2006, Cambridge: Cambridge Univ Pr.
22. Mahadevan R, Schilling CH. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metabolic engineering 2003, 5(4):264-276.
23. Shlomi T, Cabili MN, Ruppin E. Predicting metabolic biomarkers of human inborn errors of metabolism. Molecular systems biology 2009, 5:263.
24. Sigurdsson MI, Jamshidi N, Jonsson JJ, Palsson BO. Genome-scale network analysis of imprinted human metabolic genes. Epigenetics 2009, 4(1):43-46.
25. Feist AM, Palsson BO. The biomass objective function. Curr Opin Microbiol 2010, 13(3):344-349.
26. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nature protocols 2007, 2(3):727-738.
27. Sigurdsson MI, Jamshidi N, Steingrimsson E, Thiele I, Palsson BO. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst Biol 2010, 4:140.
28. Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 2006, 12(17):5018-5022.
29. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006, 580(12):2879-2887.
30. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 2001, 142(5):872-880.
31. Syrigos KN, Karapanagiotou E, Boura P, Manegold C, Harrington K. Bevacizumab-induced hypertension: pathogenesis and management. BioDrugs 2011, 25(3):159-169.
32. Yang R, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J, Jin H. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 1996, 27(6):838-844.